Skip to content
MenuOpen navigation menu

Real moms, real GLP-1 talk

“Ozempic Babies”: Fertility, Contraception and Planning

Why I would not rely on irregular cycles as contraception, what the product-specific precautions say, and what early pregnancy studies cannot prove.

Written by (pen name) — editorial research, not medical advice
On this page

What people mean by "Ozempic babies"

"Ozempic babies" is the nickname for unplanned pregnancies that women report while on a GLP-1. Two issues to discuss are that losing weight can bring ovulation back, especially with PCOS, and tirzepatide can make birth-control pills less reliable around dose increases. Wegovy's label says to stop at least two months before a planned pregnancy1,2,3.

I would read the pregnancy-exposure questions alongside the prevention question: what should be discussed before treatment begins? I would want to know what the studies actually show, which contraception instructions apply and who to contact if pregnancy is possible.

Why ovulation comes back

Carrying extra weight can quiet ovulation, and for a lot of women that becomes the background assumption: "I don't really ovulate, so I don't really worry." Then the weight starts coming off.

A 2026 review written for OB-GYNs says that in women with PCOS, meta-analyses show GLP-1s improve insulin resistance, androgen levels and ovulation rates3. Not everyone reads the evidence that confidently. A separate 2026 meta-analysis of eleven randomized trials found GLP-1s produced modest weight loss in women with PCOS, but said the evidence on menstrual regularity was too thin to draw a conclusion4.

I would not settle the disagreement by choosing the more reassuring review. The systematic review rates the evidence for reproductive outcomes as uncertain. I would still avoid using irregular cycles as contraception; previous difficulty conceiving does not establish that pregnancy is impossible now.

PCOS: the group most likely to be surprised

This is the mom I worry about most. She may have spent years being told getting pregnant would be hard. She may have stopped using anything. Then she starts a medication that might be nudging her cycle back, and the first sign is a late period she assumes is the drug.

If that's you, my PCOS piece goes through what's actually proven, and the missed-period discussion is about why a pregnancy test comes before blaming the medication.

The pill problem, briefly

Zepbound and Mounjaro slow stomach emptying enough that the label tells women on the pill to switch to a non-oral method or add a barrier method for four weeks after starting and four weeks after each dose increase2. Wegovy and Ozempic don't carry that warning. I mapped it to a real dose calendar in Zepbound and birth control.

I would not assign a cause to every unplanned pregnancy from those two possibilities. They do make a medication-specific contraception conversation important, even when there is no reliable estimate for an individual’s probability of conceiving.

Stopping before trying: what each label says

MedicineWhat the label says about planning a pregnancy
Wegovy (semaglutide)Stop at least 2 months before a planned pregnancy
Zepbound (tirzepatide)Stop when pregnancy is recognized; also the 4-week pill rule
BothWeight loss offers no benefit in pregnancy and may harm the baby

The Wegovy label gives the two-month runway because semaglutide stays in the body a long time1. I couldn't find a matching planned-pregnancy runway in the Zepbound label. It says to stop when pregnancy is recognized, and that the human data are too limited to judge the risk of birth defects or miscarriage2. That gap is exactly why the "when should I stop" question belongs with your prescriber, not a forum.

Both labels point to pregnancy exposure registries, which collect outcomes from women who conceived while taking the drug1,2. If it happens to you, joining one helps the next woman get a better answer.

What the pregnancy data show so far

A 2026 systematic review pulled together 36 studies on GLP-1 exposure around conception, in pregnancy and while breastfeeding. Across large observational studies, early exposure wasn't consistently linked to more major birth defects, stillbirth or newborn deaths, and maternal outcomes didn't show a repeatable safety signal5. The authors were careful: the data are still mostly about early exposure, not continued use.

I would read that as preliminary reassurance about the exposures studied, not proof of safety throughout pregnancy or a reason to continue without contacting the clinical team.

What I'd actually do

  • If you don't want to get pregnant: pick contraception that works for you now, not the version of you from five years ago. If you're on the pill and starting Zepbound, plan the backup windows.
  • If you do: tell your prescriber before you start trying, so the stopping date is a decision rather than an accident.
  • If your period is late: take a test before you blame the drug.

If you think you might be pregnant on a GLP-1, stop taking it and call your doctor or OB.

Frequently asked questions

What does “Ozempic babies” mean?

It is a nickname for pregnancies reported during GLP-1 treatment, not a measured pregnancy rate or an approved fertility indication. Previous irregular cycles or difficulty conceiving do not rule out pregnancy.

Do the studies establish that semaglutide directly increases fertility?

No. Small PCOS studies and reviews examine reproductive outcomes, often with different drugs or combination treatment. They do not establish a direct semaglutide effect or predict an individual pregnancy.

When should Wegovy be stopped before a planned pregnancy?

The Wegovy label says at least two months before a planned pregnancy. Arrange the timing and alternative care with the prescriber.

When should Zepbound be stopped before trying to conceive?

Its label says to discontinue when pregnancy is recognized but does not specify the same planned-pregnancy interval as Wegovy. Ask the prescriber for a medication-specific preconception plan.

Does reassuring early-exposure research prove pregnancy safety?

No. The cited review relies largely on observational evidence and cannot establish safety. Contact the prescribing and pregnancy-care teams promptly about suspected or confirmed pregnancy and follow the product instructions to discontinue treatment.

References

  1. Novo Nordisk Inc. (2026). WEGOVY (semaglutide) injection and tablets — Prescribing Information: section 8.1 Pregnancy (including the pregnancy exposure registry) and section 8.3 Females and Males of Reproductive Potential. DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  2. Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection — Prescribing Information: section 8.1 Pregnancy (including the pregnancy exposure registry) and section 8.3 contraception. DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  3. Chauhan I (2026). What obgyns need to know about GLP-1 receptor agonists. Current Opinion in Obstetrics and Gynecology. https://pubmed.ncbi.nlm.nih.gov/42108205/
  4. Forslund M, Wändell P, Forsberg L, et al. (2026). GLP-1 receptor agonist treatment in women with polycystic ovary syndrome — a systematic review and meta-analysis. European Journal of Endocrinology. https://pubmed.ncbi.nlm.nih.gov/41701618/
  5. Ozbek L, Shah E, Al-Shiab R, et al. (2026). Safety of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/41885132/

One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.